These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 37491532)

  • 1. Comparative effects of CFTR modulators on phagocytic, metabolic and inflammatory profiles of CF and nonCF macrophages.
    Aridgides DS; Mellinger DL; Gwilt LL; Hampton TH; Mould DL; Hogan DA; Ashare A
    Sci Rep; 2023 Jul; 13(1):11995. PubMed ID: 37491532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystic fibrosis transmembrane conductance regulator (CFTR) modulators have differential effects on cystic fibrosis macrophage function.
    Zhang S; Shrestha CL; Kopp BT
    Sci Rep; 2018 Nov; 8(1):17066. PubMed ID: 30459435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (R)-Roscovitine and CFTR modulators enhance killing of multi-drug resistant Burkholderia cenocepacia by cystic fibrosis macrophages.
    Shrestha CL; Zhang S; Wisniewski B; Häfner S; Elie J; Meijer L; Kopp BT
    Sci Rep; 2020 Dec; 10(1):21700. PubMed ID: 33303916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cysteamine re-establishes the clearance of Pseudomonas aeruginosa by macrophages bearing the cystic fibrosis-relevant F508del-CFTR mutation.
    Ferrari E; Monzani R; Villella VR; Esposito S; Saluzzo F; Rossin F; D'Eletto M; Tosco A; De Gregorio F; Izzo V; Maiuri MC; Kroemer G; Raia V; Maiuri L
    Cell Death Dis; 2017 Jan; 8(1):e2544. PubMed ID: 28079883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CF monocyte-derived macrophages have an attenuated response to extracellular vesicles secreted by airway epithelial cells.
    Koeppen K; Nymon A; Barnaby R; Li Z; Hampton TH; Ashare A; Stanton BA
    Am J Physiol Lung Cell Mol Physiol; 2021 Apr; 320(4):L530-L544. PubMed ID: 33471607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory Activity of Epithelial Stem Cell Variants from Cystic Fibrosis Lungs Is Not Resolved by CFTR Modulators.
    Wang S; Niroula S; Hoffman A; Khorrami M; Khorrami M; Yuan F; Gasser GN; Choi S; Liu B; Li J; Metersky ML; Vincent M; Crum CP; Boucher RC; Karmouty-Quintana H; Huang HJ; Sheshadri A; Dickey BF; Parekh KR; Engelhardt JF; McKeon FD; Xian W
    Am J Respir Crit Care Med; 2023 Nov; 208(9):930-943. PubMed ID: 37695863
    [No Abstract]   [Full Text] [Related]  

  • 7. Emerging Concepts in Defective Macrophage Phagocytosis in Cystic Fibrosis.
    Jaganathan D; Bruscia EM; Kopp BT
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal complement-mediated phagocytosis of Pseudomonas aeruginosa by monocytes is cystic fibrosis transmembrane conductance regulator-dependent.
    Van de Weert-van Leeuwen PB; Van Meegen MA; Speirs JJ; Pals DJ; Rooijakkers SH; Van der Ent CK; Terheggen-Lagro SW; Arets HG; Beekman JM
    Am J Respir Cell Mol Biol; 2013 Sep; 49(3):463-70. PubMed ID: 23617438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic fibrosis macrophage function and clinical outcomes after elexacaftor/tezacaftor/ivacaftor.
    Zhang S; Shrestha CL; Robledo-Avila F; Jaganathan D; Wisniewski BL; Brown N; Pham H; Carey K; Amer AO; Hall-Stoodley L; McCoy KS; Bai S; Partida-Sanchez S; Kopp BT
    Eur Respir J; 2023 Apr; 61(4):. PubMed ID: 36265882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered iron metabolism in cystic fibrosis macrophages: the impact of CFTR modulators and implications for Pseudomonas aeruginosa survival.
    Hazlett HF; Hampton TH; Aridgides DS; Armstrong DA; Dessaint JA; Mellinger DL; Nymon AB; Ashare A
    Sci Rep; 2020 Jul; 10(1):10935. PubMed ID: 32616918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutual Effects of Single and Combined CFTR Modulators and Bacterial Infection in Cystic Fibrosis.
    Cigana C; Giannella R; Colavolpe A; Alcalá-Franco B; Mancini G; Colombi F; Bigogno C; Bastrup U; Bertoni G; Bragonzi A
    Microbiol Spectr; 2023 Feb; 11(1):e0408322. PubMed ID: 36625583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CAGE sequencing reveals CFTR-dependent dysregulation of type I IFN signaling in activated cystic fibrosis macrophages.
    Gillan JL; Chokshi M; Hardisty GR; Clohisey Hendry S; Prasca-Chamorro D; Robinson NJ; Lasota B; Clark R; Murphy L; Whyte MKB; Baillie JK; Davidson DJ; Bao G; Gray RD
    Sci Adv; 2023 May; 9(21):eadg5128. PubMed ID: 37235648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated Mirc1/Mir17-92 cluster expression negatively regulates autophagy and CFTR (cystic fibrosis transmembrane conductance regulator) function in CF macrophages.
    Tazi MF; Dakhlallah DA; Caution K; Gerber MM; Chang SW; Khalil H; Kopp BT; Ahmed AE; Krause K; Davis I; Marsh C; Lovett-Racke AE; Schlesinger LS; Cormet-Boyaka E; Amer AO
    Autophagy; 2016 Nov; 12(11):2026-2037. PubMed ID: 27541364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystic fibrosis transmembrane conductance regulator dysfunction in platelets drives lung hyperinflammation.
    Ortiz-Muñoz G; Yu MA; Lefrançais E; Mallavia B; Valet C; Tian JJ; Ranucci S; Wang KM; Liu Z; Kwaan N; Dawson D; Kleinhenz ME; Khasawneh FT; Haggie PM; Verkman AS; Looney MR
    J Clin Invest; 2020 Apr; 130(4):2041-2053. PubMed ID: 31961827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CFTR Modulators Restore Acidification of Autophago-Lysosomes and Bacterial Clearance in Cystic Fibrosis Macrophages.
    Badr A; Eltobgy M; Krause K; Hamilton K; Estfanous S; Daily KP; Abu Khweek A; Hegazi A; Anne MNK; Carafice C; Robledo-Avila F; Saqr Y; Zhang X; Bonfield TL; Gavrilin MA; Partida-Sanchez S; Seveau S; Cormet-Boyaka E; Amer AO
    Front Cell Infect Microbiol; 2022; 12():819554. PubMed ID: 35252032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vardenafil reduces macrophage pro-inflammatory overresponses in cystic fibrosis through PDE5- and CFTR-dependent mechanisms.
    Noel S; Panin N; Beka M; Dhooghe B; Huaux F; Leal T
    Clin Sci (Lond); 2017 Jun; 131(11):1107-1121. PubMed ID: 28196856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining Ivacaftor and Intensive Antibiotics Achieves Limited Clearance of Cystic Fibrosis Infections.
    Durfey SL; Pipavath S; Li A; Vo AT; Ratjen A; Carter S; Morgan SJ; Radey MC; Grogan B; Salipante SJ; Welsh MJ; Stoltz DA; Goss CH; McKone EF; Singh PK
    mBio; 2021 Dec; 12(6):e0314821. PubMed ID: 34903059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy: A Review for the Otolaryngologist.
    Lee SE; Farzal Z; Daniels MLA; Thorp BD; Zanation AM; Senior BA; Ebert CS; Kimple AJ
    Am J Rhinol Allergy; 2020 Jul; 34(4):573-580. PubMed ID: 32168995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired functions of macrophage from cystic fibrosis patients: CD11b, TLR-5 decrease and sCD14, inflammatory cytokines increase.
    Simonin-Le Jeune K; Le Jeune A; Jouneau S; Belleguic C; Roux PF; Jaguin M; Dimanche-Boitre MT; Lecureur V; Leclercq C; Desrues B; Brinchault G; Gangneux JP; Martin-Chouly C
    PLoS One; 2013; 8(9):e75667. PubMed ID: 24098711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elexacaftor/tezacaftor/ivacaftor corrects monocyte microbicidal deficiency in cystic fibrosis.
    Cavinato L; Luly FR; Pastore V; Chiappetta D; Sangiorgi G; Ferrara E; Baiocchi P; Mandarello G; Cimino G; Del Porto P; Ascenzioni F
    Eur Respir J; 2023 Apr; 61(4):. PubMed ID: 36455959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.